NASDAQ •
Healthcare •
Medical Devices •
Quote as of 06/18/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization512.94 mln
Float182 mln
Earnings Date07/30/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.59
Likely reliable
Relative Strength
28
/ 100
Underperforming
Debt / Equity
1.44
Elevated leverage
ROE
-15.70
Negative
Dividend Yield
0.00%
No dividend
Business Description
Cerus Corporation is a California-based medical company dedicated to making blood transfusions safer. Its core product, the INTERCEPT Blood System, uses proprietary technology to eliminate harmful pathogens from donated blood components such as platelets, plasma, and red blood cells before they reach patients. The company also produces a specialized treatment for bleeding disorders related to fibrinogen deficiency, along with an LED device used in blood processing. Cerus sells its products through direct sales teams and distribution partners across the United States, Europe, the Middle East, Latin America, and beyond.
